Harm-reduction interventions in injection drug use

Lancet

Volumn 367, Issue 9525, 2006, Pages 1797-1798

  Hickman, Matthew ^a   Macleod, John ^b   De Angelis, Daniela ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; ILLICIT DRUG;

ARTICLE; CLINICAL RESEARCH; DRUG ABUSE PATTERN; DRUG LEGISLATION; DRUG MISUSE; DRUG USE; HARM REDUCTION; HEALTH CARE POLICY; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 33744524076     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68781-3     Document Type: Note

References (15)

1. Negrete J. Harm reduction: quo vadis?. Addiction 96 (2001) 543-545
2. van den Brink W., Hendriks V., Blanken P., Koeter M., van Zwieten B., and van Ree J. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 327 (2003) 310-315
3. Nordt C., and Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 367 (2006) 1830-1834
4. Hickman M., Taylor C., Chatterjee A., et al. Estimating drug prevalence: review of methods with special reference to developing countries. UN Bull Narcotics 1 & 2 (2002) 15-32
5. Gfroerer J., and Brodsky M. The incidence of illicit drug use in the United States, 1962-1989. Br J Addict 87 (1992) 1345-1351
6. Hunt L. Recent spread of heroin use in the United States. Am J Public Health 64 (1974) 16-23
7. Bishop Y., Fienberg S., and Holland P. Discrete multivariate analysis: theory and practice (1975), MIT Press, Cambridge, Massachusetts
8. Hickman M., Seaman S., and De Angelis D. Estimating the relative incidence of heroin use: application of a method for adjusting observed reports of first visits to specialist treatment agencies. Am J Epidemiol 153 (2001) 632-641
9. De Angelis D., Hickman M., and Yang S. Estimating long-term trends in the incidence and prevalence of opiate/injecting drug use and the number of ex-users: the use of back-calculation methods and opiate overdose deaths. Am J Epidemiol 160 (2004) 994-1004
10. Ben-Shlomo Y. Real epidemiologists don't do ecological studies?. Int J Epidemiol 34 (2005) 1181-1182
11. Kaplan E. Needles that kill: modelling human immunodeficiency virus transmission via shared needle injection equipment in shooting galleries. Rev Infect Dis 11 (1989) 289-298
12. Termorshuizen F., Krol A., Prins M., and van Ameijden E. Long term outcome of chronic drug use-the Amsterdam cohort study among drug users. Am J Epidemiol 161 (2005) 271-279
13. Galai N., Safaeian M., Vlahov D., Bolotin A., and Celentano D. Longitudinal patters of drug injection behaviour in the ALIVE study cohort 1988-2000; description and determinants. Am J Epidemiol 158 (2003) 695-704
14. Institute of Medicine. Pathways of addiction-opportunities in drug abuse research (1996), National Academy Press, Washington
15. Ades A., and Sutton A. Multiparameter evidence synthesis in epidemiology and medical decision making: current approaches. J R Stat Soc Series A 169 (2006) 5-35